The profitability was sustained by improved gross margins and operational efficiencies: Aurobindo Pharma VCMD | Photograph: Firm web site
Aurobindo Pharma on Saturday mentioned its consolidated web revenue elevated 61 per cent yr on yr to Rs 919 crore within the first quarter ended June 2024, aided by robust gross sales throughout markets.
The Hyderabad-based drug maker had reported a web revenue of Rs 571 crore within the April-June quarter of final fiscal.
Income from operations elevated to Rs 7,567 crore within the June quarter as in opposition to Rs 6,851 crore within the year-ago interval, the drug maker mentioned in an announcement.
“We’re happy with our continued robust efficiency this quarter, with a major top-line progress throughout all our enterprise segments,” Aurobindo Pharma Vice-Chairman and Managing Director Okay Nithyananda Reddy said.
The profitability was sustained by improved gross margins and operational efficiencies, whereas ramping up our just lately commercialised crops, he added.
“We’re assured in our means to realize our progress targets for FY25,” Reddy mentioned.
(Solely the headline and movie of this report might have been reworked by the Enterprise Customary workers; the remainder of the content material is auto-generated from a syndicated feed.)
First Printed: Aug 10 2024 | 8:25 PM IST
